This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Kempf, S., Ivankovic, S., Wiessler, M. et al. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats. Br J Cancer 52, 937–939 (1985). https://doi.org/10.1038/bjc.1985.280
Issue Date:
DOI: https://doi.org/10.1038/bjc.1985.280
This article is cited by
-
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats
British Journal of Cancer (2004)
-
Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration
Cancer Chemotherapy and Pharmacology (1994)
-
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
Cancer Chemotherapy and Pharmacology (1994)
-
Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin
Journal of Cancer Research and Clinical Oncology (1988)
-
Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats
Journal of Cancer Research and Clinical Oncology (1986)